Sara Yost, President & CEO of BostonSight, Appointed to GP Lens Institute Board of Directors

NEEDHAM, Mass. - June 10, 2020 - PRLog -- BostonSight^®, a nonprofit eye healthcare organization and research center dedicated to saving sight and improving quality of life for patients across the US, announced today that President & CEO Sara Yost, MBA, has been appointed to the Board of Directors of the GP Lens Institute (GPLI). Yost's appointment reinforces BostonSight's industry leadership in education and development of practice-building resources for eye care practitioners.

"I am honored to be appointed to the Board of Directors at GPLI," said Yost. "At BostonSight, we strive to transform the understanding, treatment, and care of complex corneal disease within the global medical community and empower practitioners to elevate the standard of care for patients. As part of GPLI's board, I'm looking forward to further empowering practitioners on the benefits of specialty lenses."

GPLI was founded in the fall of 1985 when a small, independent group of practitioners and industry representatives met to discuss the need for gas permeable education. Initially the Institute sponsored GP seminars at several professional meetings. From this modest beginning, the work of the GPLI has grown to include an extensive schools workshop program, monthly online webinars, an array of educational and practice-building materials for practitioners — most of which are online — and a bimonthly newsletter, among its many resources.

"We are thrilled to have Sara join the GPLI Board. Her many years of experience in the specialty lens field will help GPLI continue to provide practitioners with the resources they need to benefit from the many advantages of GP (gas permeable) and custom specialty soft contact lenses," said Edward S. Bennett, OD, MSEd, President and Executive Director of GPLI. "It is a privilege to work with her, and with all of our board members at the GP Lens Institute."

About BostonSight®
BostonSight^® has saved the sight of thousands of individuals suffering from ocular surface disease, corneal disease, injury, or damage with BostonSight PROSE^™ treatment. Founded in 1992, the Needham, MA Center of Excellence includes a clinic, research center, state-of-the-art FDA-certified and ISO-compliant manufacturing lab, and patient and family support center. BostonSight SCLERAL was launched in 2017 to expand access to global scleral lens technology. Eye care practitioners achieve a fast, effective scleral lens fit that provides optimal vision and comfort for patients while attaining long-term eye health. SCLERAL^IG is the newest innovation in BostonSight's portfolio, using image topography to map the eye for a truly custom fit. BostonSight envisions a world where no one suffers loss of sight from corneal irregularities or ocular surface disease. Learn more at www.bostonsight.org.

About GP Lens Institute
The GP Lens Institute (GPLI) is a 501(c)(3) non-profit dedicated to providing eye care practitioners with educational and practice-building resources to enable them to fully benefit from the many advantages of GP (oxygen permeable) and custom specialty soft contact lenses. More information may be found at www.gpli.info/